13ebcee29bc838751a6c03e2d299c4a9 301133.pdf 549a6425a145a6608dfe1a2d9601ffe11f9c364a 301133.pdf e87ebfa2d766861d42acf25a9af6658bdf2d6f5c82acdcaf0727cd94935eb7f1 301133.pdf Title: Survival by Depth of Response and Efficacy by International Metastatic Renal Cell Carcinoma Database Consortium Subgroup with Lenvatinib Plus Pembrolizumab Versus Sunitinib in Advanced Renal Cell Carcinoma: Analysis of the Phase 3 Randomized CLEAR Study Keywords: Lenvatinib, Pembrolizumab, Sunitinib, Depth of response, Renal cell carcinoma Author: Viktor Grünwald, Thomas Powles, Evgeny Kopyltsov, Vadim Kozlov, Teresa Alonso-Gordoa, Masatoshi Eto, Thomas Hutson, Robert Motzer, Eric Winquist, Pablo Maroto, Bhumsuk Keam, Giuseppe Procopio, Shirley Wong, Bohuslav Melichar, Frederic Rolland, Mototsugu Oya, Karla Rodriguez-Lopez, Kenichi Saito, Jodi McKenzie, Camillo Porta Creator: Antenna House Formatter V7.3 MR1 Linux : 7.3.2.60453 (2023-03-06T13:41+09) Producer: Antenna House PDF Output Library 7.3.1863 CreationDate: Mon Feb 19 14:17:02 2024 CET ModDate: Mon Feb 19 14:17:02 2024 CET Custom Metadata: no Metadata Stream: yes Tagged: yes UserProperties: no Suspects: no Form: none JavaScript: no Pages: 17 Encrypted: no Page size: 612 x 792 pts (letter) Page rot: 0 File size: 796131 bytes Optimized: no PDF version: 1.5 name type encoding emb sub uni object ID ------------------------------------ ----------------- ---------------- --- --- --- --------- Times-Roman Type 1 Custom no no yes 12 0 Helvetica Type 1 Custom no no yes 16 0 Times-BoldItalic Type 1 Standard no no no 20 0 Helvetica-Bold Type 1 Custom no no yes 35 0 Times-Bold Type 1 Custom no no yes 398 0 Jhove (Rel. 1.28.0, 2023-05-18) Date: 2024-09-27 02:41:26 CEST RepresentationInformation: 301133.pdf ReportingModule: PDF-hul, Rel. 1.12.4 (2023-03-16) LastModified: 2024-09-26 11:02:28 CEST Size: 796131 Format: PDF Version: 1.5 Status: Well-Formed and valid SignatureMatches: PDF-hul MIMEtype: application/pdf Profile: Tagged PDF PDFMetadata: Objects: 0 FreeObjects: 247 IncrementalUpdates: 0 DocumentCatalog: ViewerPreferences: HideToolbar: false HideMenubar: false HideWindowUI: false FitWindow: false CenterWindow: false DisplayDocTitle: false NonFullScreenPageMode: UseNone Direction: L2R ViewArea: CropBox ViewClip: CropBox PrintArea: CropBox PageClip: CropBox PageLayout: SinglePage PageMode: UseOutlines Language: EN Outlines: Item: Title: Abstract Item: Title: Introduction Item: Title: Patients and methods Children: Item: Title: Study design and patients Item: Title: Endpoints of CLEAR (study 307/KEYNOTE 581) Item: Title: Exploratory analyses Item: Title: Statistical analyses Item: Title: Results Children: Item: Title: Baseline demographic and clinical characteristics of patients Item: Title: Landmark analyses of OS Item: Title: Efficacy results among the IMDC risk subgroups Item: Title: Efficacy by presence or absence of target kidney lesions at baseline Item: Title: Characterizations of patients with a near CR Item: Title: Discussion Item: Title: Conclusions Item: Title: References Item: Title: Fig. 1   Item: Title: Fig. 2   Item: Title: Fig. 3   Item: Title: Table 1   Filters: FilterPipeline: FlateDecode FilterPipeline: DCTDecode Images: Image: NisoImageMetadata: FormatName: image/jpg CompressionScheme: JPEG ImageWidth: 152 ImageHeight: 152 ColorSpace: RGB BitsPerSample: 8 BitsPerSampleUnit: integer Image: NisoImageMetadata: FormatName: image/jpg CompressionScheme: JPEG ImageWidth: 1800 ImageHeight: 746 BitsPerSample: 8 BitsPerSampleUnit: integer Image: NisoImageMetadata: FormatName: image/jpg CompressionScheme: JPEG ImageWidth: 1351 ImageHeight: 1800 BitsPerSample: 8 BitsPerSampleUnit: integer Image: NisoImageMetadata: FormatName: image/jpg CompressionScheme: JPEG ImageWidth: 1376 ImageHeight: 1800 BitsPerSample: 8 BitsPerSampleUnit: integer Fonts: Type1: Font: BaseFont: Helvetica FirstChar: 32 LastChar: 133 FontDescriptor: FontName: Helvetica Flags: Nonsymbolic FontBBox: -166, -225, 1000, 931 EncodingDictionary: Differences: true ToUnicode: true Font: BaseFont: Helvetica-Bold FirstChar: 32 LastChar: 130 FontDescriptor: FontName: Helvetica-Bold Flags: Nonsymbolic FontBBox: -170, -228, 1003, 962 EncodingDictionary: Differences: true ToUnicode: true Font: BaseFont: Times-BoldItalic Font: BaseFont: Times-Roman FirstChar: 32 LastChar: 139 FontDescriptor: FontName: Times-Roman Flags: Nonsymbolic FontBBox: -168, -218, 1000, 898 EncodingDictionary: Differences: true ToUnicode: true Font: BaseFont: Times-Bold FirstChar: 32 LastChar: 128 FontDescriptor: FontName: Times-Bold Flags: Nonsymbolic FontBBox: -168, -218, 1000, 935 EncodingDictionary: Differences: true ToUnicode: true XMP: 2024-02-19T08:17:02-05:00 2024-02-19T08:17:02-05:00 application/pdf Antenna House PDF Output Library 7.3.1863 Lenvatinib, Pembrolizumab, Sunitinib, Depth of response, Renal cell carcinoma Antenna House Formatter V7.3 MR1 Linux : 7.3.2.60453 (2023-03-06T13:41+09) 2024-02-19T08:17:02-05:00 Survival by Depth of Response and Efficacy by International Metastatic Renal Cell Carcinoma Database Consortium Subgroup with Lenvatinib Plus Pembrolizumab Versus Sunitinib in Advanced Renal Cell Carcinoma: Analysis of the Phase 3 Randomized CLEAR Study Viktor Grünwald, Thomas Powles, Evgeny Kopyltsov, Vadim Kozlov, Teresa Alonso-Gordoa, Masatoshi Eto, Thomas Hutson, Robert Motzer, Eric Winquist, Pablo Maroto, Bhumsuk Keam, Giuseppe Procopio, Shirley Wong, Bohuslav Melichar, Frederic Rolland, Mototsugu Oya, Karla Rodriguez-Lopez, Kenichi Saito, Jodi McKenzie, Camillo Porta LenvatinibPembrolizumabSunitinibDepth of responseRenal cell carcinoma Pages: Page: Sequence: 1 Annotations: Annotation: Subtype: Link Contents: http://creativecommons.org/licenses/by/4.0/ Rect: 269, 653, 409, 661 LastModified: D:20240219081702-05'00' Page: Sequence: 2 Annotations: Annotation: Subtype: Link Contents: https://doi.org/10.1016/j.euo.2023.01.010 Rect: 272, 96, 405, 104 LastModified: D:20240219081702-05'00' Page: Sequence: 3 Page: Sequence: 4 Page: Sequence: 5 Page: Sequence: 6 Page: Sequence: 7 Page: Sequence: 8 Page: Sequence: 9 Page: Sequence: 10 Annotations: Annotation: Subtype: Link Contents: https://seer.cancer.gov/statfacts/html/kidrp.html Rect: 317, 164, 489, 173 LastModified: D:20240219081702-05'00' Annotation: Subtype: Link Contents: https://gco.iarc.fr/today/home Rect: 490, 151, 515, 160 LastModified: D:20240219081702-05'00' Annotation: Subtype: Link Contents: gco.iarc.fr/today/home Rect: 170, 140, 251, 149 LastModified: D:20240219081702-05'00' Page: Sequence: 11 Annotations: Annotation: Subtype: Link Contents: http://www.nccn.org/professionals/physician_gls/PDF/kidney.pdf Rect: 370, 483, 496, 492 LastModified: D:20240219081702-05'00' Annotation: Subtype: Link Contents: physician_gls/PDF/kidney.pdf Rect: 170, 472, 278, 481 LastModified: D:20240219081702-05'00' Page: Sequence: 12 Page: Sequence: 13 Page: Sequence: 14 Page: Sequence: 15 Page: Sequence: 16 Page: Sequence: 17 Checksum: d52cbfcf Type: CRC32 Checksum: 13ebcee29bc838751a6c03e2d299c4a9 Type: MD5 Checksum: 549a6425a145a6608dfe1a2d9601ffe11f9c364a Type: SHA-1 Checksum: e87ebfa2d766861d42acf25a9af6658bdf2d6f5c82acdcaf0727cd94935eb7f1 Type: SHA-256